CRMD
CorMedix Inc.NASDAQHealthcare$7.05+0.43%ClosedMarket Cap: $557.3M
As of 2026-04-06
Valuation
P/E (TTM)
3.42
PEG
0.00
P/B
1.37
P/S
1.79
EV/EBITDA
3.39
DCF Value
$2.56
FCF Yield
31.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
88.5%
Operating Margin
48.2%
Net Margin
52.3%
ROE
58.5%
ROA
39.1%
ROIC
24.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $128.6M | 83.4% | $59.1M | $14.0M | $0.15 | — |
| FY 2025 | $311.7M | 88.5% | $150.1M | $163.1M | $2.04 | — |
| Q3 2025 | $104.3M | 89.3% | $51.3M | $108.6M | $1.26 | — |
| Q2 2025 | $39.7M | 95.3% | $19.5M | $19.8M | $0.28 | — |
| Q1 2025 | $39.1M | 95.9% | $20.1M | $20.6M | $0.30 | — |
| Q4 2024 | $31.2M | 96.2% | $12.9M | $13.5M | $0.22 | — |
| FY 2024 | $43.5M | 92.7% | $-22.4M | $-17.9M | $-0.30 | — |
| Q3 2024 | $11.5M | 94.0% | $-3.3M | $-2.8M | $-0.05 | — |
| Q2 2024 | $806.1K | 36.8% | $-15.3M | $-14.2M | $-0.25 | — |
| Q1 2024 | $0.00 | -Infinity% | $-16.7M | $-14.5M | $-0.25 | — |
| Q4 2023 | $0.00 | -Infinity% | $-15.7M | $-14.8M | $-0.26 | — |
| FY 2023 | $0.00 | -Infinity% | $-49.0M | $-46.3M | $-0.91 | — |